These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21947887)

  • 21. Have the renin-angiotensin-aldosterone system perturbations in cardiovascular disease been exhausted?
    Mansur SJ; Hage FG; Oparil S
    Curr Cardiol Rep; 2010 Nov; 12(6):450-63. PubMed ID: 20827517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis PA; Ruilope LM
    Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Salt-induced inappropriate augmentation of intrarenal RAAS and its treatment in patients with chronic kidney disease].
    Konishi Y
    Nihon Rinsho; 2012 Sep; 70(9):1588-92. PubMed ID: 23012808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New aspects of hypertension management in patients with chronic kidney disease].
    Vakilzadeh N; Phan O; Forni Ogna V; Burnier M; Wuerzner G
    Rev Med Suisse; 2014 Sep; 10(441):1668-72. PubMed ID: 25322626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Intrarenal angiotensin II generation as a hypertensinogenic mechanism.
    Gonzalez-Villalobos RA; Fuchs S
    J Appl Physiol (1985); 2010 Dec; 109(6):2013. PubMed ID: 21188829
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin D in chronic kidney disease: new potential for intervention.
    Mirković K; van den Born J; Navis G; de Borst MH
    Curr Drug Targets; 2011 Jan; 12(1):42-53. PubMed ID: 20795938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease.
    Bovée DM; Uijl E; Severs D; Rubio-Beltrán E; van Veghel R; Maassen van den Brink A; Joles JA; Zietse R; Cuevas CA; Danser AHJ; Hoorn EJ
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F654-F668. PubMed ID: 33586496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neprilysin inhibition and chronic kidney disease].
    Di Lullo L; Ronco C; Bellasi A; Cozzolino M; Floccari F; Barbera V; Verdesca S; Rivera R; De Pascalis A; Mudoni A; Santoro A
    G Ital Nefrol; 2017 Sep; 34(5):102-112. PubMed ID: 28963831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension.
    Muñoz-Durango N; Fuentes CA; Castillo AE; González-Gómez LM; Vecchiola A; Fardella CE; Kalergis AM
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy.
    Rivoli L; Di Mario F; Coppolino G; Gigante A; Barbano B; Farrah TE; Rosato E; Fuiano G; Cianci R
    Curr Drug Metab; 2016; 17(6):550-8. PubMed ID: 26892730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.
    Mennuni S; Rubattu S; Pierelli G; Tocci G; Fofi C; Volpe M
    J Hum Hypertens; 2014 Feb; 28(2):74-9. PubMed ID: 23803592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major barriers against renin-angiotensin-aldosterone system blocker use in chronic kidney disease stages 3-5 in clinical practice: a safety concern?
    Yildirim T; Arici M; Piskinpasa S; Aybal-Kutlugun A; Yilmaz R; Altun B; Erdem Y; Turgan C
    Ren Fail; 2012; 34(9):1095-9. PubMed ID: 22950572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-Angiotensin System Control for Chronic Kidney Disease Patients Undergoing Coronary Surgery.
    Yoshitake I; Sezai A; Hata M; Osaka S; Kimura H; Hata H; Shiono M
    Ann Thorac Cardiovasc Surg; 2016 Oct; 22(5):291-297. PubMed ID: 27558882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.
    Tkachenko O; Helal I; Shchekochikhin D; Schrier RW
    Curr Hypertens Rev; 2013 Feb; 9(1):12-20. PubMed ID: 23971639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study.
    Tylicki L; Jakubowska A; Lizakowski S; Świetlik D; Rutkowski B
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):145-52. PubMed ID: 25324423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the efficacy of RAAS blockade in patients with chronic kidney disease.
    Lambers Heerspink HJ; de Borst MH; Bakker SJ; Navis GJ
    Nat Rev Nephrol; 2013 Feb; 9(2):112-21. PubMed ID: 23247573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD; Bucher BS; Tschumi S; Lava SA; Bianchetti MG
    Minerva Pediatr; 2012 Apr; 64(2):171-82. PubMed ID: 22495191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.